4
Changes in Ownership
RELMADA THERAPEUTICS, INC. Filed Acc 0001213900-21-005448
CEO sold 10,000 shares at an average $32.39 ($323,914)
- CEO acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
TRAVERSA SERGIO · CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 1 in the form | +10,000 | $3.24 | $32,400 | 85,493 | D |
| 2021-01-27 | Sale : show line 2 in the form | −4,351 | $31.77 | $138,231 | 81,142 | D |
| 2021-01-27 | Sale : show line 3 in the form | −5,549 | $32.86 | $182,340 | 75,593 | D |
| 2021-01-27 | Sale : show line 4 in the form | −100 | $33.43 | $3,343 | 75,493 | D |
| Open-market sales · 10,000 sh · avg $32.39 · $323,914 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 5 in the form Options to purchase common stock | −10,000 | 148,422 | D |
Loading xslF345X03/ownership.xml…